PainReform Ltd.
PRFX
$0.97
$0.011.05%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 40.96% | 16.46% | -10.45% | -4.00% | -32.41% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -83.88% | -78.72% | -75.27% | -34.80% | 226.15% |
| Operating Income | 83.88% | 78.72% | 75.27% | 34.80% | -226.15% |
| Income Before Tax | 84.16% | 78.97% | 81.96% | -2,547.22% | -235.26% |
| Income Tax Expenses | -- | -- | -50.00% | -- | -- |
| Earnings from Continuing Operations | 84.16% | 78.97% | 81.91% | -2,558.33% | -235.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 84.16% | 78.97% | 81.91% | -2,558.33% | -235.26% |
| EBIT | 83.88% | 78.72% | 75.27% | 34.80% | -226.15% |
| EBITDA | 85.11% | 80.35% | 75.34% | 34.95% | -226.56% |
| EPS Basic | 97.60% | 99.16% | 99.20% | -203.33% | 52.63% |
| Normalized Basic EPS | 97.60% | 99.16% | 99.20% | -202.86% | 52.63% |
| EPS Diluted | 97.60% | 99.16% | 99.20% | -203.33% | 52.63% |
| Normalized Diluted EPS | 97.60% | 99.16% | 99.20% | -202.86% | 52.63% |
| Average Basic Shares Outstanding | 560.29% | 2,416.00% | 2,149.85% | 2,280.91% | 608.37% |
| Average Diluted Shares Outstanding | 560.29% | 2,416.00% | 2,149.85% | 2,280.91% | 608.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |